JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down Syndrome

JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down Syndrome

Summary: Individuals with Down syndrome (DS; trisomy 21) display hyperactivation of interferon (IFN) signaling and chronic inflammation, which could potentially be explained by the extra copy of four IFN receptor (IFNR) genes encoded on chromosome 21. However, the clinical effects of IFN hyperactivi...

Full description

Bibliographic Details
Main Authors:	Kathryn D. Tuttle, Katherine A. Waugh, Paula Araya, Ross Minter, David J. Orlicky, Michael Ludwig, Zdenek Andrysik, Matthew A. Burchill, Beth A.J. Tamburini, Colin Sempeck, Keith Smith, Ross Granrath, Dayna Tracy, Jessica Baxter, Joaquin M. Espinosa, Kelly D. Sullivan
Format:	Article
Language:	English
Published:	Elsevier 2020-11-01
Series:	Cell Reports
Subjects:	Down syndrome trisomy 21 interferon cytokine storm JAK inhibitors autoimmunity
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211124720313966

Similar Items

Trisomy 21 consistently activates the interferon response
by: Kelly D Sullivan, et al.
Published: (2016-07-01)

JAK inhibition decreases the autoimmune burden in Down syndrome
by: Angela L Rachubinski, et al.
Published: (2024-12-01)

Signaling a link between interferon and the traits of Down syndrome
by: Gina Kirsammer, et al.
Published: (2016-09-01)

An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
by: Maddison Lensing, et al.
Published: (2022-08-01)

Loss of JAK1 Drives Innate Immune Deficiency
by: Agnieszka Witalisz-Siepracka, et al.
Published: (2019-01-01)

Treatment of Atopic Dermatitis Using JAK Inhibitors: A Systematic Review
by: Stefan Siedlikowski, et al.
Published: (2019-11-01)

JAK/STAT in leukemia: a clinical update
by: Dong Liang, et al.
Published: (2024-01-01)

Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic Dermatitis
by: Helena Iznardo, et al.
Published: (2023-01-01)

JAK ACADEMY in Rheumatoid Arthritis (RA)
by: Roberto Caporali, et al.
Published: (2018-09-01)

JAK2 in Myeloproliferative Neoplasms: Still a Protagonist
by: Michael Stephan Bader, et al.
Published: (2022-01-01)

Outcome after Prenatal Diagnosis of Trisomy 13, 18, and 21 in Fetuses with Congenital Heart Disease
by: Stephanie Springer, et al.
Published: (2022-08-01)

The Many Faces of JAKs and STATs Within the COVID-19 Storm
by: Alice H. Grant, et al.
Published: (2021-07-01)

JAK inhibitors: a new choice for diabetes mellitus?
by: Mengjun Zhou, et al.
Published: (2025-01-01)

JAK Inhibitors and Modulation of B Cell Immune Responses in Rheumatoid Arthritis
by: Rita A. Moura, et al.
Published: (2021-02-01)

Immunolocalization and Expression of JAK1 and JAK3 in the Skin of Dust Mite-Sensitive Beagle Dogs before and after Allergen Exposure
by: Roberta Sartori, et al.
Published: (2023-08-01)

Emerging systemic JAK inhibitors in the treatment of atopic dermatitis: a review of abrocitinib, baricitinib, and upadacitinib
by: Novin Nezamololama, et al.
Published: (2020-11-01)

Systemic Treatment of Psoriasis with JAK Inhibitors: A Review
by: Amanda Kvist-Hansen, et al.
Published: (2019-12-01)

Small molecule drug discovery targeting the JAK-STAT pathway
by: You Lv, et al.
Published: (2024-06-01)

JAK Be Nimble: Reviewing the Development of JAK Inhibitors and JAK Inhibitor Combinations for Special Populations of Patients with Myelofibrosis
by: Andrew T. Kuykendall, et al.
Published: (2021-08-01)

Association of JAK/STAT genetic variants with cutaneous melanoma
by: Gabriela Vilas Bôas Gomez, et al.
Published: (2022-08-01)

A novel JAK/ROCK inhibitor, CPL409116, demonstrates potent efficacy in the mouse model of systemic lupus erythematosus
by: Maria Dulak-Lis, et al.
Published: (2021-04-01)

Exploring the role of Janus kinase (JAK) in atopic dermatitis: a review of molecular mechanisms and therapeutic strategies
by: Toshiaki Kogame, et al.
Published: (2023-07-01)

The natural history of pregnancies with prenatal diagnosis of Trisomy 18 or Trisomy 13: Retrospective cases of a 23-year experience in a Brazilian public hospital
by: Julio Alejandro Peña Duque, et al.

Perspectives of JAK Inhibitors for Large Vessel Vasculitis
by: Ryu Watanabe, et al.
Published: (2022-03-01)

Emerging Topical and Systemic JAK Inhibitors in Dermatology
by: Farzan Solimani, et al.
Published: (2019-12-01)

The role of JAK2 abnormalities in hematologic neoplasms.
by: Mohammed Khalid Alabdulaali
Published: (2009-07-01)

Refractory granuloma faciale successfully treated with adjunct topical JAK inhibitor
by: Ailynna Chen, MPH, et al.
Published: (2023-03-01)

JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology
by: Meredyth G. Ll Wilkinson, et al.
Published: (2021-09-01)

Editorial: JAK inhibition in autoimmune and inflammatory diseases
by: Jean-Baptiste Telliez, et al.
Published: (2022-12-01)

Unusual Lifespan of Edwards' Syndrome in COVID-19 Era
by: Filla Reviyani Suryaningrat, et al.
Published: (2024-09-01)

Operative and nonoperative outcomes in patients with trisomy 13 and 18 with congenital heart diseaseCentral MessagePerspective
by: Christina L. Greene, MD, et al.
Published: (2024-08-01)

Low-level mosaic trisomy 20 without uniparental disomy 20 at amniocentesis in a pregnancy associated with a favorable outcome, cytogenetic discrepancy between uncultured amniocytes and cultured amniocytes and perinatal progressive decrease of the aneuploid cell line
by: Chih-Ping Chen, et al.
Published: (2023-05-01)

Analysis of Second Trimester Maternal Quadruple Screening Test for Trisomy 21 and Trisomy 18
by: Katja Bricelj, et al.
Published: (2014-10-01)

Mosaic trisomy 15 at amniocentesis: Prenatal diagnosis, molecular genetic analysis and literature review
by: Chih-Ping Chen, et al.
Published: (2015-08-01)

Cytogenetic discrepancy between uncultured amniocytes and cultured amniocytes in mosaic trisomy 15 at amniocentesis
by: Chih-Ping Chen, et al.
Published: (2020-09-01)

Cardiac surgery in children with trisomy 13 or trisomy 18: How safe is it?Central MessagePerspective
by: Joshua M. Rosenblum, MD, PhD, et al.
Published: (2022-12-01)

Mosaic trisomy 12 at amniocentesis: Prenatal diagnosis and molecular genetic analysis
by: Chih-Ping Chen, et al.
Published: (2013-03-01)

Exploring the Novel Dimension of Immune Interactions in Pain: JAK Inhibitors’ Pleiotropic Potential
by: Krasimir Kraev, et al.
Published: (2023-09-01)

Insights, current status and future perspective of JAK inhibitors in the treatment of alopecia areata
by: Xingqi ZHANG
Published: (2022-04-01)

Association of JAK2 Haplotype GGCC_46/1 with the Response to Onco-Drug in MPNs Patients Positive for JAK2V617F Mutation
by: Michela Perrone, et al.
Published: (2024-09-01)